Your browser does not support SVG.
HOME
PIPELINE
LEADERSHIP
DISEASES
Acne vulgaris
Atopic dermatitis
Hyperhidrosis
Psoriasis
Vitiligo
NEWS
CAREERS
CONTACT
December 2016
December 2016
December 21, 2016
Licensing of Topical Cerdulatinib ...
Read More
Recent Posts
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit
Dermavant Appoints Todd Zavodnick as Chief Executive Officer
Dermavant Sciences to Present Tapinarof Phase 2B Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference
Dermavant Announces Changes to Leadership and Board of Directors
Dermavant Sciences Announces Closing of Transaction with GSK for Purchase of Rights to Tapinarof
Archives
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
April 2018
September 2017
July 2017
December 2016
November 2015
Categories
Dermavant Sciences
News
RVT-201
RVT-501
RVT-502
RVT-504
Tapinarof
